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Abstract—Objective: To evaluate the predictive utility of self-reported and informant-reported functional deficits in
patients with mild cognitive impairment (MCI) for the follow-up diagnosis of probable AD. Methods: The Pfeffer Func-
tional Activities Questionnaire (FAQ) and Lawton Instrumental Activities of Daily Living (IADL) Scale were administered
at baseline. Patients were followed at 6-month intervals, and matched normal control subjects (NC) were followed
annually. Results: Self-reported deficits were higher for patients with MCI than for NC. At baseline, self- and informant-
reported functional deficits were significantly greater for patients who converted to AD on follow-up evaluation than for
patients who did not convert, even after controlling for age, education, and modified Mini-Mental State Examination
scores. While converters showed significantly more informant- than self-reported deficits at baseline, nonconverters
showed the reverse pattern. Survival analyses further revealed that informant-reported deficits (but not self-reported
deficits) and a discrepancy score indicating greater informant- than self-reported functional deficits significantly predicted
the development of AD. The discrepancy index showed high specificity and sensitivity for progression to AD within 2
years. Conclusions: These findings indicate that in patients with MCI, the patient’s lack of awareness of functional deficits
identified by informants strongly predicts a future diagnosis of AD. If replicated, these findings suggest that clinicians
evaluating MCI patients should obtain both self-reports and informant reports of functional deficits to help in prediction of
long-term outcome.
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In addition to progressive loss of cognitive skills, a
core feature of a clinical diagnosis of AD is a decline
in the ability to perform tasks required for indepen-
dent living (see Diagnostic and Statistical Manual of
Mental Disorders, 4th ed. [DSM-IV],1 and National
Institute of Neurological and Communication Disor-
ders and Stroke/Alzheimer’s Disease and Related
Disorders Association2-4 criteria). In the early stages
of AD, performance of daily household activities es-
sential to maintaining independence (instrumental
activities of daily living [IADL]) is altered.5 In later
stages, there is a progressive decline in basic activi-
ties involving self-care and mobility (ADL).3-5 Numer-
ous studies6-11 have demonstrated that a large
proportion of patients diagnosed with mild to moder-
ate AD lack full awareness of this progressive
decline.
Less is known about the functional status of el-
derly patients with mild cognitive impairment
(MCI). The term “mild cognitive impairment,” which
has varying definitions and criteria, is used by our
group to broadly define older individuals whose cog-
nitive deficits are worse than those typical of normal
aging but not severe enough to warrant a diagnosis
of dementia.12 Many studies of MCI have been con-
cerned with psychometric differentiation of these
subjects from normal elderly and patients with AD,
and the investigation of functional competence in
people with MCI has been limited.
A recent study by Albert et al.13 from our group
investigated self-reported and informant-reported
(e.g., spouse or child of proband) functional conse-
quences of cognitive impairment in elderly patients
who met criteria for MCI according to the Clinical
Dementia Rating Scale (CDR).14,15 These patients fell
into two subcategories: those with a CDR score of 0,
denoting “nondementia” but with evidence of subtle
cognitive impairment with or without functional
complaints, and those with a CDR score of 0.5, de-
noting “questionable dementia” or evidence of mild to
moderate cognitive and functional impairment. Be-
cause the MCI patients in the Albert et al. study13
were mildly impaired, functional batteries designed
to assess higher levels of functioning were used,
namely, the Pfeffer Functional Activities Question-
naire (FAQ)16 and Lawton IADL Scale.17 Analyses
comparing self- and informant-reported deficits re-
vealed that these patients with MCI, particularly
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those with a CDR score of 0.5, tended to overesti-
mate their functional abilities. While this finding is
consistent with the “lack of awareness” observed in
AD patients, to our knowledge, this was the first
report of diminished awareness of functional deficits
in MCI patients.
A related potential predictor is a discrepancy be-
tween patient and informant reports of cognitive sta-
tus. While studies have shown that self-reported
memory complaints are predictive of cognitive im-
pairment and dementia,18-21 a recent study22 that ex-
amined the predictive utility of self- and informant-
reported cognitive deficits (e.g., changes in memory
for lists, events, and names of people) found that
only informant-reported deficits predicted risk of AD
at 2-year follow-up.
The goal of the current prospective study was to
assess discrepancies between self- and informant-
reported functional deficits in MCI patients as a pre-
dictor of incident AD and to determine the
sensitivity and specificity of different degrees of such
discrepancy. In the current study, MCI patients and
normal comparison subjects (NC) were followed sys-
tematically in a clinical setting. The subjects com-
prised a larger sample than in the earlier cross-
sectional Albert et al. report.13 Deficits in household
competencies were assessed at baseline evaluation
with the Pfeffer FAQ16 and the Lawton IADL,17 both
of which have been extensively validated and used in
gerontologic research. They were separately admin-
istered to the patient and an informant (i.e., signifi-
cant other) and to NC (subject only).
We hypothesized that at baseline evaluation, MCI
patients, particularly those with a CDR score of 0.5,
would demonstrate a lack of awareness of functional
deficits, defined as having a greater number of
informant-reported than self-reported functional def-
icits. More specifically, we hypothesized that
informant-reported functional deficits would be a
better predictor of a future diagnosis of AD than
self-reported functional deficits and that higher
scores on a discrepancy index (i.e., informant-
reported minus self-reported deficits) would particu-
larly increase the risk of incident AD. Evaluating the
predictive utility of self- vs informant-reported func-
tional deficits in MCI patients is important, given
that functional scales are often administered in clin-
ical settings to elderly patients and informants and
therefore could potentially be used by primary care
physicians for early detection of AD.
Methods. Subjects. Outpatients with MCI who pre-
sented for evaluation at a memory disorders center were
recruited for a prospective study that examined putative
early diagnostic markers of AD. NC (n  46) were group
matched to MCI patients (n  107) for age, sex, and years
of education. Of the 107 MCI patients evaluated at base-
line, 48 met diagnostic criteria (see inclusion criteria be-
low) for minimal cognitive impairment (CDR of 0) and 59
for “questionable dementia” (CDR of 0.5). Patients were
examined at 6-month intervals, and NC were examined
annually. The institutional review boards of the New York
State Psychiatric Institute and Columbia Presbyterian
Medical Center approved the research protocol, and writ-
ten informed consent was obtained from each patient.
Procedures. For patients with MCI, inclusion criteria
were age 40 years, intellectual impairment for 6
months and 10 years, and the diagnosis of “nondemented
with minimal cognitive impairment” (CDR of 0) or “ques-
tionably demented” (CDR of 0.5). MCI patients had a mod-
ified Mini-Mental State (mMMS)23 score of 40 of 57
(equivalent to an MMS24 score of 22). The following defi-
cits on neuropsychological testing served as screening
guidelines: impairment in memory, as evidenced by recall
of two of three objects or fewer after 5 minutes on the
MMS or a delayed recall score of 1 SD below norm in the
six-trial Selective Reminding Test25 or impaired intellec-
tual performance as evidenced by a Wechsler Adult Intelli-
gence Scale–Revised performance IQ 10 points below the
verbal IQ score. Patients who did not reveal any of the
neuropsychological deficits were still eligible for participa-
tion if they met the following criteria: subjective com-
plaints of a decline in memory or cognitive functioning,
objective evidence of this decline identified by an infor-
mant, and clinically significant functional impairment
based on a positive score on at least one of the first eight
items of the modified Blessed Functional Activity Scale.26
Exclusion criteria were a diagnosis of dementia, schizo-
phrenia, schizoaffective disorder, or primary major affec-
tive disorder that clearly preceded the onset of cognitive
impairment, electroconvulsive therapy within the last 6
months, current or recent (last 6 months) history of alcohol
or substance dependence (DSM-IV criteria),1 clinical or his-
torical evidence of stroke (cortical stroke or an infarct 2
cm in diameter on any MRI slice; periventricular hyperin-
tensities and small subcortical lacunae or infarcts did not
lead to exclusion), cognitive impairment caused by concom-
itant medications, and the presence of major neurologic
illness (e.g., PD or ALS). These inclusion and exclusion
criteria defined a relatively broad group of patients be-
tween “normal” and “dementia” and are similar to those
used in other studies of MCI.12,27 Based on a comprehen-
sive review of all available clinical and diagnostic informa-
tion, a consensus diagnosis by expert raters determined
CDR status and study entry.28
Functional assessment scales. The Pfeffer FAQ16 and
the Lawton IADL Scale17 were administered by a neuro-
psychology technician at baseline to all MCI patients and
NC. In addition, these scales were independently adminis-
tered to the informants of all patients (CDR of 0 and 0.5).
NC did not have informants.
The Pfeffer FAQ comprises 10 items that assess a vari-
ety of IADL and complex cognitive/social functions. These
include writing checks, paying bills, and keeping financial
records; assembling tax or business records; shopping
alone; playing games of skill; making coffee or tea; prepar-
ing a balanced meal; keeping track of current events; pay-
ing attention and understanding while reading or
watching a TV show; remembering appointments, family
occasions, and to take medications; and traveling out of the
neighborhood. The eight items of the Lawton IADL Scale
assess housekeeping, shopping, traveling to places out of
walking distance, doing laundry, handling finances, taking
medications, telephoning, and meal preparation.
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For the Pfeffer FAQ and Lawton IADL Scale, each item
was scored dichotomously (no difficulty/any difficulty), and
the sum of items rated as “any difficulty” (Pfeffer FAQ
range: 0 to 10; Lawton IADL range: 0 to 8) was calculated
for each subject. If a subject had never performed the task
(lifetime), the item was excluded from analyses.
Statistical analyses. Two-tailed t-tests and 2 tests
were used to compare the baseline demographic and clini-
cal features and functional deficits of MCI patients (CDR
of 0 and 0.5) and NC. Similar tests were used to compare
the baseline characteristics and self- and informant-
reported functional deficits of MCI patients with and with-
out the follow-up diagnosis of dementia.
A discrepancy index was calculated by subtracting the
number of self-reported deficits from the number of
informant-reported deficits. The discrepancy score distri-
bution was dichotomized to compare subjects who had
greater informant- than self-reported functional deficits vs
those who did not (i.e., showed no discrepancy or had
greater self- than informant-reported deficits).
To test for group differences in baseline self- and
informant-reported deficits in the patient groups with
CDR scores of 0 and 0.5, a two-way analysis of covariance
(ANCOVA) was performed, where rater (baseline self-
report vs informant report) served as the within-subjects
factor and diagnostic group (CDR of 0 vs 0.5) as the
between-subjects factor. Age, education, and mMMS scores
were covariates. ANCOVA, with the same covariates, was
also used to compare baseline self- and informant-reported
deficits for MCI patients who did or did not receive a
diagnosis of AD on follow-up.
Survival analysis (Cox proportional hazards model) was
used to examine the effect of predictors on the develop-
ment of AD. Subjects were considered to have met the AD
endpoint if they met criteria for AD at two consecutive
assessments (6-month intervals). The time variable was
the time from the initial visit to the first follow-up at
which a diagnosis of AD was made. Predictor variables
investigated were the total number of baseline self-
reported deficits, the total number of baseline informant-
reported deficits, and the discrepancy index. Age, years of
education, and mMMS scores were used as covariates. To
further assess the predictive utility of the discrepancy in-
dex, CDR status was entered into the regression equation
as an additional covariate. In addition, a separate Cox
analysis was conducted in which CDR status was the main
predictor with age, years of education, and mMMS scores
as covariates.
Logistic regression analyses, including the discrepancy
index, age, education, and mMMS scores as predictor vari-
ables, were also conducted after restricting the group with
MCI to patients who had completed the 2-year follow-up
(or developed AD before that time). Sensitivity and speci-
ficity for the 2-year follow-up diagnosis of AD were calcu-
lated for the informant-reported deficit variable and the
discrepancy index. Positive and negative predictive value
was also calculated for a cutoff score of 1 on the discrep-
ancy index.
Results. Baseline sample. A breakdown of the demo-
graphic and clinical feature s for the NC and MCI patient
groups is presented in tables 1 and 2. Independent t-tests
comparing demographic variables for the patients with
CDR of 0 and NC revealed no differences for age (p 
0.741), years of education (p  0.727), or mMMS scores
(p  0.118).
Baseline self- and informant-reported deficits. On av-
erage, NC self-reported fewer baseline Pfeffer and Lawton
IADL deficits than did patients (see table 1). Informant-
reported deficits were not available for NC.
In the MCI sample, self- and informant-reported deficits










Sex, % F 50.5 54.3 NS
Age, y, mean  SD 67.6  10.1 63.8  9.7 0.032
Education, y, mean  SD 15.2  3.6 16.5  2.7 0.030
mMMS score, range: 0–57,
mean  SD
51.7  4.3 54.9  1.5 0.001
MMS score, range: 0–30,
mean  SD
27.5  2.2 29.4  0.78 0.001
Pfeffer deficits,
mean  SD
1.79  1.93 0.007  0.33 0.001
Lawton IADL deficits,
mean  SD
0.42  0.96 0.00 †
* A test of significance for 2 (categorical variables) or two-tailed
t-test (continuous variables) conducted as appropriate.
† Among normal controls, no one endorsed Lawton IADL deficits,
and therefore a statistical comparison was not conducted.
MCI  mild cognitive impairment; mMMS  modified Mini-
Mental State; IADL  Instrumental Activities of Daily Living
Scale.
Table 2 Baseline characteristics and self- and informant-reported
functional deficits of patients with mild cognitive impairment








Sex, % F 41.7 57.6 NS
Age, y, mean  SD 63.2  9.9 71.2  8.8 0.001
Education, y, mean  SD 16.7  2.4 13.9  4.0 0.001
mMMS score, mean  SD 54.2  2.5 49.6  4.4 0.001
MMS score, mean  SD 28.7  1.5 26.6  2.2 0.001
Pfeffer self-reported deficits,
mean  SD
1.9  2.1 1.7  1.8 NS
Pfeffer informant-reported
deficits, mean  SD
1.5  2.0 2.0  2.1 NS
IADL self-reported deficits,
mean  SD
0.4  0.9 0.5  0.9 NS
IADL informant-reported
deficits, mean  SD
0.3  0.7 0.8  1.4 NS
* A test of significance for 2 (categorical variables) or two-tailed
t-test conducted as appropriate.
CDR  Clinical Dementia Rating Scale; mMMS  modified
Mini-Mental State; IADL  Instrumental Activities of Daily Liv-
ing Scale.
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did not differ between the groups with CDR of 0 and 0.5
(see table 2). On average, the group with CDR of 0 re-
ported more deficits than their informants and the group
with CDR of 0.5 showed the opposite pattern (i.e., the
mean number of informant-reported deficits was greater
than self-reported deficits). However, these differences did
not achieve statistical significance. ANCOVA using the to-
tal number of deficits as the dependent variable and in
which age, years of education, and mMMS scores were
used as covariates did not reveal any significant main ef-
fects or higher-order interactions of diagnostic group (CDR
of 0 vs 0.5) or rater (self vs informant).
There were, however, more self-reported and informant-
reported Pfeffer FAQ deficits than Lawton IADL deficits
for both groups with CDR of 0 (self-report: paired t[47] 
5.63, p  0.0001; informant report: paired t[47]  5.19, p 
0.0001) and CDR of 0.5 (self-report: paired t[58]  6.48,
p  0.0001; informant report: paired t[58]  6.02, p 
0.0001).
Follow-up sample. Of the 107 MCI patients evaluated
at baseline, at least one semiannual follow-up evaluation
was available in 92 patients. Fifty-three of the 92 (58%)
patients had a baseline CDR of 0.5 and 39 (42%) had a
baseline CDR of 0. The mean duration of follow-up was
24.5 months (SD 14.3 months). The number of subjects
followed up at each time point was 85 at 6 months, 75 at
12 months, 55 at 18 months, 52 at 24 months, 30 at 30
months, 27 at 36 months, 14 at 42 months, 10 at 48
months, and 3 at 54 months. Of the 92 patients followed,
all 23 who met consensus diagnostic criteria for dementia
during follow-up also met criteria for probable AD. Three
of the 23 incident dementia cases had a progressive clinical
course consistent with AD plus other conditions (parkin-
sonism, depression, vascular disease) that were deemed
contributing factors. All 23 patients were retained for all
analyses.
Sex was not associated with a final diagnosis of AD
(men: 9/46 [19.6%]; women: 14/46 [30.4%]; 2  1.4, df  1,
p  0.229), nor was it associated with the predictor vari-
ables (i.e., self-reported deficits, informant-reported defi-
cits, and discrepancy index). Higher mean age (64.4 vs 75.6
years; t  5.0, df  90, p  0.001), fewer mean years of
education (15.8 vs 13.5 years; t  2.8, df  90, p  0.007),
and lower mean mMMS scores (52.6 vs 48.8; t  3.9, df 
90, p  0.001) at baseline were each associated with the
diagnosis of AD at follow-up. Therefore, these three vari-
ables were used as covariates in subsequent analyses.
To compare group differences in baseline self- and
informant-reported functional deficits for MCI patients
who received a diagnosis of AD on follow-up (n  23) vs
those who did not (n  69), a two-way rater (baseline
self-report vs informant report) by diagnostic group (“con-
verters” to AD vs “nonconverters”) ANCOVA was per-
formed using the total number of deficits as the dependent
variable and in which age, education, and mMMS scores
were covariates. For the Pfeffer FAQ, there was a main
effect of diagnostic group (F[1,87]  7.7, p  0.007), no
main effect of rater, and a rater  diagnostic group inter-
action (F[1,87]  6.6, p  0.012) (see figure 1). Post hoc
linear contrasts revealed that (1) there were no differences
in baseline self-reported deficits between converters and
nonconverters (p  0.243), (2) informant-reported deficits
were greater for converters than nonconverters (contrast
estimate  2.0, SE  0.54, p  0.001, 95% CI  0.92 to
3.1), and (3) the difference between the mean number of
informant- and self-reported deficits for the group that
converted to AD was larger than that of the nonconverters
(contrast estimate  1.3, SE  0.47, p  0.007, 95% CI 
0.38 to 2.3). In similar analyses using the Lawton IADL
Scale instead of the Pfeffer FAQ Scale, there were no sig-
nificant main effects or higher-order interactions.
Prediction of AD at follow-up. Separate Cox propor-
tional hazards models were used to evaluate the effect of
baseline Pfeffer self-reported and informant-reported defi-
cits on the endpoint diagnosis of AD. The total number of
self-reported deficits did not predict time to develop AD
(Wald 2  0.001, df  1, p  0.977, relative risk [RR] 
1.0, 95% CI  0.8 to 1.2), with age (p  0.002), years of
education (p  0.721), and mMMS scores (p  0.079) in-
cluded in the Cox model as covariates. In contrast, the
total number of informant-reported deficits did predict
time to develop AD (Wald 2  7.6, df  1, p  0.006,
RR  1.3, 95% CI  1.1 to 1.6) when age (p  0.001), years
of education (p  0.448), and mMMS scores (p  0.057)
were included as covariates.
The predictive utility of the dichotomous discrepancy
index (i.e., informant- minus self-reported deficits) was
also evaluated. A cutoff point of 1 (i.e., at least one more
informant-reported deficit than self-reported deficits) on
the Pfeffer FAQ was examined. The log-rank test revealed
distribution differences between the two index groups (log
rank statistic  17.6, df  1, p  0.0001). The Cox propor-
tional hazards model revealed a relative risk for reaching
the endpoint diagnosis of AD of 4.4 (95% CI  1.8 to 10.6,
Figure 1. Significant rater (baseline self-report vs infor-
mant report)  diagnostic group (nondemented vs de-
mented on follow-up) interaction, revealing greater
informant-reported than self-reported baseline functional
deficits for patients with mild cognitive impairment (MCI)
(n  23) who met criteria for AD on follow-up and the re-
verse pattern for MCI patients (m  69) who did not con-
vert to AD (the means adjusted for age, education, and
modified Mini-Mental State scores as described in text).
Filled circles  self-report; open circles  informant re-
port; error bars  SEM. FAQ  Functional Activities
Questionnaire.
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Wald 2  10.8, df  1, p  0.001), after controlling for age
(p  0.018), years of education (p  0.825), and mMMS
scores (p  0.047). The cumulative incidence curves for the
dichotomous discrepancy variable (evaluated at the mean
of the covariates in the model) are presented in figure 2.
The relative risk of AD remained significant even after
baseline CDR status was included in the regression equa-
tion as an additional covariate (dichotomized discrepancy
index: Wald 2  11.1, df  1, p  0.001, RR  4.7, 95%
CI  1.9 to 11.5; CDR status, p  0.145; mMMS, p 
0.114; age, p  0.070; years of education, p  0.824). More-
over, CDR status alone did not predict time to develop AD
(Wald 2  2.7, df  1, p  0.100, RR  3.7, 95% CI  0.7
to 18.0), with age (p  0.007), years of education (p 
0.616), and mMMS scores (p  0.765) included in the Cox
model as covariates. When a cutoff point of 1 on the
Lawton IADL Scale was used as the discrepancy index
predictor in the Cox proportional hazards model, it did not
relate to risk of AD (Wald 2  2.6, df  1, p  0.078, RR
 2.6, 95% CI  0.9 to 7.2; mMMS, p  0.057; age, p 
0.004; years of education, p  0.762).
To evaluate clinically relevant prediction, further anal-
yses were conducted by restricting the clinical group with
mild cognitive impairment to patients who had completed
2 years of follow-up (n  52) or patients who had already
developed AD by 2 years (n  3). In this subsample of 55
patients with MCI (13 who had and 42 who had not devel-
oped AD), self-report (AD: mean Pfeffer FAQ score  1.4,
SD  1.6; non-AD: mean  2.4, SD  2.3; t  1.5, df  53,
p  0.150) and informant report (AD: mean Pfeffer FAQ
score  2.5, SD  2.0; non-AD: mean  2.0, SD  2.3; t 
0.8, df  53, p  0.426) by themselves did not predict AD
on follow-up, but the baseline Pfeffer FAQ discrepancy
score predicted AD on follow-up (AD: mean discrepancy
score  1.2, SD  2.5; non-AD: mean  0.4, SD  1.6;
t  2.7, df  53, p  0.010). In a logistic regression analy-
sis that evaluated the outcome of AD at 2-year follow-up, a
discrepancy score of 1 (i.e., dichotomized discrepancy
variable) predicted AD (odds ratio [OR]  7.9, 95% CI 
1.3 to 49.6, p  0.028) when age (p  0.065), years of
education (p  0.989), and mMMS scores (p  0.138) were
also included in the model.
For this subgroup followed up at 2 years, baseline
informant-reported deficits of 1 led to 84.6% sensitivity
(n  11/16 converters) and 38.1% specificity (n  16/42
nonconverters) for the diagnosis of AD (see table 3). A
progressive decrease in sensitivity and an increase in spec-
ificity were observed with more informant-reported defi-
cits. The optimal tradeoff between sensitivity and
specificity occurred at two or more informant-reported def-
icits (sensitivity  61.5% [n  8/13] and specificity 
57.1% [n  24/42]). For the informant- vs self-reported
discrepancy index, the optimal tradeoff between sensitivity
and specificity occurred at a discrepancy score of 1 (sen-
sitivity  61.5% [n  8/13] and specificity  83.3 [n 
35/42]) with a positive predictive value of 73% and a nega-
tive predictive value of 61% based on a 42% (23/55) preva-
lence in this sample followed for 2 years.
Discussion. While lack of awareness of functional
deficits is characteristic of patients with mild to
moderate AD, only a few studies have examined this
issue in patients with MCI. In a cross-sectional study
of a smaller sample from this same series of subjects,
Albert et al.13 reported that MCI patients, particu-
larly those with a CDR of 0.5, overestimated their
functional abilities compared with informant reports.
The MCI patients in the current larger sample also
revealed greater self- and informant-reported deficits
than did NC. Moreover, at baseline, both groups of
patients and their informants endorsed a greater
number of Pfeffer FAQ than Lawton IADL deficits.
With respect to the follow-up sample, baseline func-
tional deficits as measured by the Pfeffer FAQ were
Figure 2. Cumulative incidence curves (evaluated at the
mean of the covariates in the Cox model) showing the
probability of developing AD over a 4.5-year period in sub-
jects with mild cognitive impairment at baseline, by the
presence or absence of greater informant-reported than
self-reported functional deficits at baseline. Solid line 
self  informant; broken line  informant  self.
Table 3 Sensitivity and specificity of functional deficits
(informant-reported and informant- vs self-reported discrepancy)
as measured by Pfeffer Functional Activities Scale in predicting









Sensitivity Specificity Sensitivity Specificity
1 84.6 38.1 61.5 83.3
2 61.5 57.1 46.2 92.9
3 46.2 64.3 23.1 97.6
4 30.8 78.6 23.1 97.6
5 23.1 81.0 7.7 97.6
6 7.7 90.5 0 100
7 0 95.2 0 100
Values are percentages.
* Three patients had not yet been followed up for the full 2 years
but had already developed AD.
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greater for patients who converted to AD on
follow-up evaluation than for patients who did not,
even after controlling for age, education, and mMMS
scores. Also, the mean number of informant-reported
Pfeffer FAQ deficits was greater than the mean
number of self-reported deficits for patients who con-
verted to AD. Moreover, while converters and non-
converters did not differ on self-reported deficits,
informants reported more deficits for converters.
These findings strongly suggest that a subset of MCI
patients overestimate higher-level functional abili-
ties and that this apparent lack of awareness pre-
dicts a future diagnosis of AD.
Survival analyses further revealed that on the
Pfeffer FAQ, informant-reported deficits (but not
self-reported deficits) and a discrepancy index score
of 1 (indicating greater informant- than self-
reported functional deficits) predicted time to de-
velop AD after controlling for age, education, and
mMMS scores. The discrepancy index was predictive
even when controlling for CDR status. On the other
hand, CDR status did not predict AD. When the sam-
ple was restricted to patients with 2 years of follow-
up, only the baseline discrepancy index predicted a
diagnosis of AD, with relatively high levels of diag-
nostic specificity and moderate sensitivity. Logistic
regression analyses further revealed that a discrep-
ancy score of 1 strongly predicted AD at the 2-year
follow-up point with an OR of 7.9 (after covarying for
age, years of education, and mMMS score). Together,
these findings confirm our hypotheses that
informant-reported, but not self-reported, higher-
level functional deficits predict time to dementia and
that among the three measures, the best predictor of
time to dementia is the disparity between self-
reports and informant reports, indicating lack of
awareness of functional deficits.
These findings have important clinical implica-
tions. They underscore the need for primary care
physicians not only to assess functional complaints
of nondemented elderly individuals but also to obtain
ratings from an informant, preferably a family mem-
ber or close acquaintance, who can reliably report on
the patient’s ability to perform daily activities re-
quired for independent living. Identical standardized
ratings, using the Pfeffer or another scale assessing
similar functions, should be obtained from both the
patient and the informant. When a disparity be-
tween these two sources is noted (showing greater
informant- than patient-reported deficits), a physi-
cian’s index of suspicion should be heightened, par-
ticularly if mental status deficits are also noted, and
the possibility of an early diagnosis of AD and appro-
priate interventions should be considered.
Our findings are consistent with those of Tierney
et al.,22 which showed that informant- but not self-
reported cognitive deficits (e.g., memory for lists,
events, and names, finding one’s way around home
and neighborhood, and financial management as
measured by the Cambridge Mental Disorders of the
Elderly Examination [CAMDEX] scale29) predict a
future diagnosis of AD in nondemented patients with
memory impairment. In the current study, two func-
tional scales were used to assess self- and informant-
reported functional deficits in MCI patients. The
difference in the frequency of reported functional
deficits between these two scales is most likely due
to the fact that the Pfeffer FAQ, in addition to as-
sessing IADL, measures changes in activities repre-
senting relatively complex household competencies
and occupational and social functioning (see Spec-
tor30 for comparison of scales). These higher-level
functions are most likely to be affected in MCI pa-
tients who, by definition, experience only mild levels
of cognitive and functional impairment. In this re-
gard, our findings suggest that in MCI, the predic-
tive utility of the Pfeffer FAQ, which captures
changes in complex activities representing higher
levels of social and cognitive functioning, is superior
to that of the Lawton IADL Scale, which measures
basic household competencies. Also, while CDR sta-
tus did not predict AD in our sample, a discrepancy
in Pfeffer FAQ deficits was highly predictive (even
after controlling for CDR status). These findings sug-
gest that in MCI, greater informant- than self-
reported deficit as measured by the Pfeffer FAQ is a
more powerful predictor of AD than CDR status.
Another important issue when assessing func-
tional competence in the elderly is the use of
performance-based vs informant-based evaluations.
Performance-based evaluations assess functional ca-
pacity directly by asking the patient to perform an
activity, which is then evaluated in a formal way.
While performance-based measures are thought to
be more objective and reliable than informant re-
ports, their use in clinical settings is limited by the
fact that their administration requires significantly
more time, specialized equipment, and highly
trained assessors and must occur under rigorously
controlled environmental conditions.11,30-33 In con-
trast, physicians or nonmedical support staff can
routinely administer self-/informant-based scales in
a cost-effective manner. In addition, the fact that the
self-/informant ratings in the current study predicted
incident AD over time provides an independent
source of validation for their use in making a differ-
ential diagnosis between benign cognitive impair-
ment and possible early AD in patients with MCI.
In conclusion, our findings provide preliminary
validation for the clinical utility of informant- vs self-
reported functional deficits in predicting a future di-
agnosis of AD in patients with MCI. Self- and
informant-reported ratings should also be used in
follow-up visits to monitor functional changes and
the effectiveness of early intervention strategies.3
On a precautionary note, this study sample in-
volved elderly patients presenting for clinical ser-
vices; therefore, the predictive utility of functional
deficits may differ in a random sample of elderly
patients. However, the careful characterization of
patients and rigorous definition of MCI used in this
study provide confidence that elderly patients with
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MCI, who also demonstrate a discrepancy between
self- and informant-reported functional deficits, are
at increased risk for a future diagnosis of AD. Con-
tinued follow-up of these individuals will enable us
to test the longer-range predictive utility of func-
tional deficits in patients with MCI. Independent
replication in larger clinical samples is also needed
to establish clinical utility.
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